metricas
covid
Buscar en
Atención Primaria
Toda la web
Inicio Atención Primaria La asistencia prehospitalaria en los síndromes coronarios agudos. Experiencia d...
Journal Information
Vol. 27. Issue 7.
Pages 478-483 (January 2001)
Share
Share
Download PDF
More article options
Vol. 27. Issue 7.
Pages 478-483 (January 2001)
Full text access
La asistencia prehospitalaria en los síndromes coronarios agudos. Experiencia del grupo ARIAM
Pre-hospital care in acute coronary syndromes. experience of the ariam group
Visits
8091
E. Aguayo de Hoyos
Corresponding author
eaguayo@ariam.net

Correspondencia: Unidad de Cuidados Intensivos. Hospital Virgen de las Nieves. Avda. Fuerzas Armadas, s/n. 18014 Granada.
, A. Reina Toral, M. Ruiz Bailén, M. Colmenero Ruiz, M. García Delgado, Grupo ARIAM
Hospital Universitario Virgen de las Nieves (Granada) y Hospital de Poniente. El Ejido. Almería
This item has received
Article information
Objetivo

El avance en el tratamiento de los síndromes coronarios agudos trata de configurar una asistencia integral, no sólo de acelerar el tratamiento fibrinolítico.

El objetivo del presente trabajo es evaluar medidas básicas de asistencia prehospitalaria de los pacientes con síndromes coronarios agudos.

Diseño

Estudio descriptivo.

Emplazamiento

Hospitalario.

Participantes

Pacientes diagnosticados de infarto agudo de miocardio o angina inestable derivados a unidades de cuidados intensivos de 70 hospitales (registro ARIAM).

Los pacientes se catalogan dependiendo de sus antecedentes coronarios isquémicos previos y al sistema que acuden primero. Se evalúa la atención prestada mediante un score específico, con especial atención en medidas elementales: administración de ácido acetilsalicílico y nitroglicerina y realización de ECG.

Mediciones y resultados

Entre 30.746 pacientes, de los que un 70,4% presentaba infarto agudo de miocardio y el 29,6% angina inestable, con 3:1 de relación varón/mujer, el score medio de atención prehospitaria alcanza un punto. Acude por sus propios medios un 48,5%, haciéndolo el resto por dispositivos de atención urgente. Se administró nitroglicerina al 36,7% y ácido acetilsalicílico a un 13,1%. Entre los pacientes con antecedentes, estas proporciones se mantienen.

Entre los dispositivos tampoco la presencia de antecedentes parece determinar una actitud diferente.

La evolución temporal no ha experimentado cambios espectaculares y las tendencias al alza observadas son más acusadas para las medidas menos establecidas.

Conclusiones

Dentro de la evaluación de la asistencia prehospitalaria a los síndromes coronarios agudos existen numerosas oportunidades de mejora que hay que desarrollar en varios frentes y donde estén implicados todos los estamentos de la asistencia sanitaria.

Palabras clave:
Infarto de miocardio
Angina inestable
Medición del proceso
Manejo de pacientes
Dispensa de los cuidados sanitarios
Objective

The advance in the treatment of the acute coronary syndromes tries to configure an integral attendance, not only of accelerating the fibrinolityc therapy.

The objective of the present work is to evaluate basic measures of the patients’ out of hospital attendance with acute coronary syndromes.

Design

Descriptive study.

Setting

Hospital center.

Patients

Diagnosed patients of myocardial infartion or unstable angina derived to intensive care units of 70 hospitals (ARIAM registry).

The patients are classified depending on their previous coronary antecedents and to the system that you/they go first. The attention is evaluated by means of an specific score, with special attention in basic measures: administration of acetil-salicilic acid and nitroglycerine and realization of ECG.

Measurements and main

Among 30746 patients, of those that 70.4% was myocardial infartion and 29.6% unstable angina, with 3:1 of relationship male/female, the half score of out of hospital attention reaches 1 point. 48.5% goes for its means, making it the rest for devices of urgent attention. It was administered troglicerina to 36.7% and acetil-salicilic acid to 13.1%. Among the patients with antecedents, these proportions remain.

Among the devices the presence of antecedents seems neither to determine a different attitude.

The temporary evolution has not suffered spectacular changes and the tendence to the observed rise, they are more marked for the less established measures.

Conclusions

Inside the evaluation of the out of hospital attendance to the acute coronary syndromes exist numerous opportunities of improvement that it is necessary to develop to several fronts and where all the sanitary services involved will be implied.

Key words:
Myocardial infarction
Unstable angina
Process measures
Patient care management
Health care delivery
Full text is only aviable in PDF
Biblografía
[1.]
S. Sans Menéndez, G. Paluzie Ávila.
Tendencias de la mortalidad por enfermedades cardiovasculares en España, 1970-1993.
Cardiopatía isquémica,
[2.]
J. Marrugat, R. Elosúa, M. Gil.
Epidemiología de la enfermedad coronaria.
Síndromes coronarios agudos,
[3.]
E. Braunwald, E. Antman.
Evidencebased coronary care.
Ann Intern Med, 126 (1997), pp. 551-553
[4.]
E. Eppler, M.S. Eisenberg, S. Schaeffer, H. Meischke, M.P. Larson.
911 and emergency department use for chest pain: results of a media campaign.
Ann Emerg Med, 24 (1994), pp. 202-208
[5.]
M.B. Blohm, M. Hartford, B.W. Karlson, R.V. Luepker, J. Herlitz.
An evaluation of the results of media and educational campaigns designed to shorten the time taken by patients with acute myocardial infarction to decide to go to hospital.
Heart, 76 (1996), pp. 430-434
[6.]
M. Álvarez Bueno, A. Vera Almazán, J.J. Rodríguez García, J.A. Ferriz Martín, T. García Paredes.
García Alcántara A y Grupo del Proyecto ARIAM. Concepto, desarrollo y objetivos.
Med Intensiva, 23 (1999), pp. 273-279
[7.]
J. McMurray, A. Ranvis.
Treatment of myocardial infarction, unstable angina, and angina pectoris.
BMJ, 309 (1994), pp. 1343-1350
[8.]
E. Aguayo de Hoyos, A. Reina Toral, M. Colmenero Ruiz, M. Barranco Ruiz, MD Pola Gallego de Guzmán, MM Jiménez Quintana, grupo ARIAM.
Análisis de los retrasos en el tratamiento del síndrome coronario agudo. Datos del Registro ARIAM.
Med Intensiva, 23 (1999), pp. 280-287
[9.]
J.M. Rowley, P. Mounser, E.A. Harrison, A.M. Skene, J.R. Hampton.
Management of myocardial infarction: implications for current policy delivered from the Nottingham Heart Attack Register.
Br Heart J, 67 (1992), pp. 255-262
[10.]
T.J. Ryan, E.M. Antman, N.H. Brooks, R.M. Califf, L.D. Hillis, L.F. Hiratzka, et al.
1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. Executive summary and recommendations. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
Circulation, 100 (1999), pp. 1016-1030
[11.]
The pre-hospital management of acute heart attacks. Recommendations of a Task Force of the The European Society of Cardiology and The European Resuscitation Council.
Eur Heart J, 19 (1998), pp. 1140-1164
[12.]
C.F.M. Weston, W.J. Penny.
Julian DG on behalf of the British Heart Foundation Working Group. Guidelines for the early management of patients with myocardial infarction.
BMJ, 308 (1994), pp. 767-771
[13.]
Antiplatelet Trialists’ Collaboration.
Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.
BMJ, 308 (1994), pp. 81-106
[14.]
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction.
Lancet, 11 (1988), pp. 349-360
[15.]
Joint Commission on Accreditation of Healthcare Organizations.
1994 Acreditation Manual for Hospitals – Volume I. Standards.
[16.]
S. Yusuf, R. Collins, S. MacMahon, R. Peto.
Effects of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.
Lancet, 1 (1988), pp. 1088-1092
[17.]
Gruppo Italiano per lo Studio della Sopravivenza nell’Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction.
Lancet, 343 (1994), pp. 1115-1122
[18.]
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.
ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction.
Lancet, 345 (1995), pp. 669-685
[19.]
The Task Force on the Management of Acute Myocardial Infarction of the The European Society of Cardiology.
Acute myocardial infarction: pre-hospital and in-hospital management.
Eur Heart J, 17 (1996), pp. 43-63
[20.]
E. Antman, E. Braunwald.
Acute myocardial infarction.
Heart disease. A text book of cardiovascular medicine, 5.a, pp. 1184-1232
[21.]
C.H. Hennekens, C.M. Albert, S.L. Godfried, J.M. Gaziano, J.E. Buring.
Adjuntive therapy of acute myocardial infarction – Evidence from clinical trials.
N Engl J Med, 335 (1996), pp. 1660-1667
[22.]
K. Dracup, A. Alonzo, J. Atkins, N. Bennett, A. Braslow, C. Lutter, et al.
The physician's role in minimizing prehospital dealy in patients at high risk for acute myocardial infarction: recommendations from The National Heart Attack Alert Program.
Ann Intern Med, 126 (1997), pp. 645-651
[23.]
M.J. Eisenberg, E.J. Topol.
Prehospital administration of aspirin in patients with unstable angina and acute myocardial infarction.
Arch Intern Med, 156 (1996), pp. 1506-1510
[24.]
J.M. Gaspoz, C. Lovis, Y. Green, C. Heliot, S. Mischler, L. Sechaud, et al.
Do physicians modify their prehospital management of patients in response to a public campaign on chest pain?.
Am J Cardiol, 81 (1998), pp. 1433-1438
[25.]
M.D. Cabana, C.S. Rand, N.R. Powe, A.W. Wu, M.H. Wilson, P.C. Abboud, et al.
Why don’t physicians follow clinical practice guidelines? A framework for improvement.
JAMA, 282 (1999), pp. 1458-1465
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos